192 related articles for article (PubMed ID: 30117739)
1. Proteasome versus Thioredoxin Reductase Competition as Possible Biological Targets in Antitumor Mixed Thiolate-Dithiocarbamate Gold(III) Complexes.
Quero J; Cabello S; Fuertes T; Mármol I; Laplaza R; Polo V; Gimeno MC; Rodriguez-Yoldi MJ; Cerrada E
Inorg Chem; 2018 Sep; 57(17):10832-10845. PubMed ID: 30117739
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms and proposed targets for selected anticancer gold compounds.
Casini A; Messori L
Curr Top Med Chem; 2011; 11(21):2647-60. PubMed ID: 22039866
[TBL] [Abstract][Full Text] [Related]
3. The anticancer effect related to disturbances in redox balance on Caco-2 cells caused by an alkynyl gold(I) complex.
Sánchez-de-Diego C; Mármol I; Pérez R; Gascón S; Rodriguez-Yoldi MJ; Cerrada E
J Inorg Biochem; 2017 Jan; 166():108-121. PubMed ID: 27842247
[TBL] [Abstract][Full Text] [Related]
4. Novel Gold(I) Thiolate Derivatives Synergistic with 5-Fluorouracil as Potential Selective Anticancer Agents in Colon Cancer.
Atrián-Blasco E; Gascón S; Rodrı Guez-Yoldi MJ; Laguna M; Cerrada E
Inorg Chem; 2017 Jul; 56(14):8562-8579. PubMed ID: 28682069
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
[TBL] [Abstract][Full Text] [Related]
6. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
[TBL] [Abstract][Full Text] [Related]
7. Gold(I) complexes of water-soluble diphos-type ligands: synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition.
Wetzel C; Kunz PC; Kassack MU; Hamacher A; Böhler P; Watjen W; Ott I; Rubbiani R; Spingler B
Dalton Trans; 2011 Sep; 40(36):9212-20. PubMed ID: 21826354
[TBL] [Abstract][Full Text] [Related]
8. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
[TBL] [Abstract][Full Text] [Related]
9. Anticancer profile of a series of gold(III) (2-phenyl)pyridine complexes.
Rubbiani R; Zehnder TN; Mari C; Blacque O; Venkatesan K; Gasser G
ChemMedChem; 2014 Dec; 9(12):2781-90. PubMed ID: 25377650
[TBL] [Abstract][Full Text] [Related]
10. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
[TBL] [Abstract][Full Text] [Related]
11. Gold(III)-dithiocarbamato complexes induce cancer cell death triggered by thioredoxin redox system inhibition and activation of ERK pathway.
Saggioro D; Rigobello MP; Paloschi L; Folda A; Moggach SA; Parsons S; Ronconi L; Fregona D; Bindoli A
Chem Biol; 2007 Oct; 14(10):1128-39. PubMed ID: 17961825
[TBL] [Abstract][Full Text] [Related]
12. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
Milacic V; Chen D; Ronconi L; Landis-Piwowar KR; Fregona D; Dou QP
Cancer Res; 2006 Nov; 66(21):10478-86. PubMed ID: 17079469
[TBL] [Abstract][Full Text] [Related]
13. Protein targets for anticancer gold compounds: mechanistic inferences.
Gabbiani C; Messori L
Anticancer Agents Med Chem; 2011 Dec; 11(10):929-39. PubMed ID: 21864237
[TBL] [Abstract][Full Text] [Related]
14. Cobaltoceniumethynyl gold(I) as an unusual heterodinuclear bioorganometallic fragment to study the biological properties of alkynyl gold complexes.
Vanicek S; Kopacka H; Wurst K; Vergeiner S; Kankowski S; Schur J; Bildstein B; Ott I
Dalton Trans; 2016 Jan; 45(4):1345-8. PubMed ID: 26732365
[TBL] [Abstract][Full Text] [Related]
15. Organogold(III)-dithiocarbamate compounds and their coordination analogues as anti-tumor and anti-leishmanial metallodrugs.
de Andrade Querino AL; de Sousa AM; Thomas SR; de Lima GM; Dittz D; Casini A; do Monte-Neto RL; Silva H
J Inorg Biochem; 2023 Oct; 247():112346. PubMed ID: 37536162
[TBL] [Abstract][Full Text] [Related]
16. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
17. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.
Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I
Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
[TBL] [Abstract][Full Text] [Related]
19. New cyclometalated gold (III) complex targeting thioredoxin reductase: exploring as cytotoxic agents and mechanistic insights.
Abyar F; Tabrizi L
Biometals; 2020 Jun; 33(2-3):107-122. PubMed ID: 32246384
[TBL] [Abstract][Full Text] [Related]
20. Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation.
Zhang C; Hemmert C; Gornitzka H; Cuvillier O; Zhang M; Sun RW
ChemMedChem; 2018 Jun; 13(12):1218-1229. PubMed ID: 29603648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]